This paper is in the following e-collection/theme issue:

Apps, Mobile, Wearables for Diabetes (298) Diabetes Self-Management (484) Telemedicine for Diabetes (95) Design and Usability of Consumer Health Tech and Home Monitoring Devices (218)

Published on in Vol 8 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43991, first published .
Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non–Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data

Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non–Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data

Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non–Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data

Authors of this article:

Robert Dowd1 Author Orcid Image ;   Lauren H Jepson1 Author Orcid Image ;   Courtney R Green2 Author Orcid Image ;   Gregory J Norman3 Author Orcid Image ;   Roy Thomas2 Author Orcid Image ;   Keri Leone2 Author Orcid Image
Article Authors Cited by (7) Tweetations (3) Metrics

Journals

  1. Aleppo G, Hirsch I, Parkin C, McGill J, Galindo R, Kruger D, Levy C, Forlenza G, Umpierrez G, Grunberger G, Bergenstal R. Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking. Diabetes Technology & Therapeutics 2023;25(10):741 View
  2. Kim J, Jin S, Andrade S, Chen B, Kim J. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis. Diabetes Technology & Therapeutics 2024;26(6):394 View
  3. Wright E, Roberts G, Chuang J, Nabutovsky Y, Virdi N, Miller E. Initiating GLP-1 Therapy in Combination with FreeStyle Libre Provides Greater Benefit Compared with GLP-1 Therapy Alone. Diabetes Technology & Therapeutics 2024;26(10):754 View
  4. Seufert J, Dänschel I, Gölz S, Haller N, Kulzer B, Tan S, Schnell O, Wiesner T, Kroeger J. Kontinuierliche Glukosemessung bei Menschen mit Typ-2-Diabetes ohne intensivierte Insulintherapie: eine Standortbestimmung. Diabetologie und Stoffwechsel 2024;19(05):356 View
  5. Miller E, Miller K. Detection and Intervention: Use of Continuous Glucose Monitoring in the Early Stages of Type 2 Diabetes. Clinical Diabetes 2024;42(3):398 View
  6. Garg S, Hirsch I, Repetto E, Snell‐Bergeon J, Ulmer B, Perkins C, Bergenstal R. Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis. Diabetes, Obesity and Metabolism 2024;26(11):5202 View